Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Videos
Specialty Devices
Drug Delivery Devices
Return to: MDBR Home | Specialty Devices | Drug Delivery Devices

Drug Delivery Devices

EMA approves Aptar Pharma’s electronic lockout device Aptar Pharma, a world leader in innovative drug delivery systems, has announced the approval by the European Medicines Agency (EMA) of the first integrated electronic nasal lockout device (e-Lockout) following a multi-year development with Takeda Pharmaceuticals International.
Specialty Devices > Drug Delivery Devices > News
QT Vascular signs asset purchase option agreement with Medtronic QT Vascular has entered into an asset purchase option agreement with Medtronic, for the acquisition of its non-drug coated Chocolate PTA.
Specialty Devices > Drug Delivery Devices > News FDA approves Medtronic’s Resolute Onyx drug-eluting stent By MDBR Staff Writer
Medtronic has secured approval from the US Food and Drug Administration (FDA) for its Resolute Onyx drug-eluting stent (DES).
Specialty Devices > Drug Delivery Devices > News
See more Drug Delivery Devices news

Latest Drug Delivery Devices News and Insight

View all Drug Delivery Devices news or find news targeted to your interests
QT Vascular signs asset purchase option agreement with Medtronic
QT Vascular has entered into an asset purchase option agreement with Medtronic, for the acquisition of its non-drug coated Chocolate PTA.
Specialty Devices > Drug Delivery Devices > News
Connect with SHL at Prefilled Syringe Seminar 2017 Tokyo
SHL Group is excited to announce that it will exhibit at the Prefilled Syringes Seminar 2017 Tokyo on 23-24 May, 2017.
Specialty Devices > Drug Delivery Devices > Press Releases
FDA approves Medtronic’s Resolute Onyx drug-eluting stent
By MDBR Staff Writer
Medtronic has secured approval from the US Food and Drug Administration (FDA) for its Resolute Onyx drug-eluting stent (DES).
Specialty Devices > Drug Delivery Devices > News
Mylan hit with class-action lawsuit over EpiPen price increase
By MDBR Staff Writer
A group of EpiPen purchasers have filed a class-action lawsuit against drugmaker Mylan over the increase of EpiPen prices by around 574%.
Specialty Devices > Drug Delivery Devices > News
maxon motor: High-performance motion control in practice
Fast control technology and dynamic, precise drive components increase the production output of machines and improve the quality and dimensional accuracy of products. This enables machine builders to offer competitive, high-performance solutions. Producers benefit from higher output quantities, and the customer gets a better product. Everybody wins.
Specialty Devices > Drug Delivery Devices > Case Studies
Lubrizol LifeSciences at Medtec EU 2017: Polymers. Formulation. Manufacturing.
Need solutions for medical device development? Lubrizol LifeSciences is your medical device + pharmaceutical solutions partner. LifeSciences is uniquely positioned as the only development partner offering polymer customization, formulation for drug eluting devices and contract manufacturing services.
Specialty Devices > Drug Delivery Devices > Press Releases
Lubrizol LifeSciences will Showcase Expanded Medical Device Solutions at Medtec EU 2017
The Lubrizol Corporation’s LifeSciences business will showcase its total solutions capabilities at Medtec Europe 2017 (Booth #1N25), April 4-6th at Messe Stuttgart in Stuttgart, Germany. Lubrizol LifeSciences is uniquely positioned as the only medical solutions partner offering polymer customization, development services for drug eluting devices and contract manufacturing services.
Specialty Devices > Drug Delivery Devices > Press Releases
View all Drug Delivery Devices news or find news targeted to your interests